Chunqiu Tan, Associate Chief Physician, Subject Leader of Pediatrics, Master of Pediatrics.2013 Graduated from Harbin Medical University, she has been engaged in pediatrics clinical work for more than 10 years. She studied at Beijing Children's Hospital of Capital Medical University for 1 year. Since her appointment, she has been engaged in both outpatient emergency work and ward work, and has been able to accurately recognize critical illnesses and give correct and effective treatments in time, so that the patients are out of danger and get a new life. She has been recognized by children and their families and has received several silk flags. Academic position: Member of Beijing Society of Integrative Medicine Children's Rheumatology and Immunology Committee; Member of China Physicians Association Pediatricians Branch Children's Rheumatology and Immunology Group, Member of Chinese Medical Association Rheumatology and Immunology Group of Pediatrics; Member of the Second Committee of Inner Mongolia Autonomous Region Physicians Association Rheumatology and Immunology Branch; Member of Inner Mongolia Physicians Association Pediatrics Branch; Member of Inner Mongolia Maternal and Child Health Care Association Pediatrics Branch. She is a member of China Eugenics Association; she has published more than 10 papers and a monograph on pediatrics.

Meili Sun, Assistant Director of Oncology, Deputy Chief Physician, Doctor of Oncology, Postdoctoral, Master's Supervisor of Shandong University, Visiting Scholar of Karolinska Institutet of Sweden, Outstanding Young Talent of Qilu Health and Health, Young Academic Leader of Jinan City. She has been engaged in oncology professional work for more than ten years, has rich clinical experience, and is familiar with the frontier trends of the profession. The main research direction is tumor radiotherapy and targeted therapy and immunotherapy of gastrointestinal tumors. Currently serving as the executive director of the First Youth Council of the Shandong Anti-Cancer Association, a member of the Precision Medicine Branch of the Shandong Medical Association, a member of the Gastrointestinal Tumor Professional Committee of the Shandong Anti-Cancer Association, and a member of the Clinical Translational Medicine Professional Committee of the Shandong Medical Biotechnology Society. Secretary of Jinan Anti-Cancer Association. She presided over one project of National Natural Science Foundation and several projects in Jinan, published 18 SCI papers and 4 papers in Chinese. She won the second prize of Jinan Science and Technology Progress Award (first place), the first prize of Shandong Health Science and Technology Award (first place), the second prize of Shandong Medical Science and Technology Award (second place), and the Outstanding Physician Award of China Medical Education Association.

Dr. Mario Mandalà received his medical degree from the Faculty of Medicine, Catholic University of Rome, Italy. He completed residency trainings in Medical Oncology and Haematology and since then he has consistently been active in medical research. He is currently Head of the Melanoma Unit, Division of Oncology, Papa Giovanni XIII Hospital in Bergamo, Italy. In this position, he coordinates a prospective outcome research project and several clinical trials investigating new therapeutic strategies (including target therapies and immunotherapies) in melanoma and gastrointestinal cancer patients. Dr. Mandala has been recently appointed chairman of the systemic treatment of the EORTC melanoma group. He is full member of the European Society of Medical Oncology. He is Reviewer for several scientific journals, including Journal of Clinical Oncology, Lancet Oncology, Cancer, British Journal of Cancer, European journal of cancer, Annals of Oncology, Cancer Treatment Review, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Arteriosclerosis-Thrombosis and Vascular Biology, Critical Reviews in Oncology and Haematology. He has authored more than 120 publications and his major scientific interests are clinical and translational research on melanoma, gastrointestinal cancer and thromboembolic complications in cancer patients. Since 2008, he gave major contributions in ESMO, AIOM and ISTH clinical practice guidelines on the management of Melanoma as well as venous thromboembolism in solid tumors.

Matteo Ravaioli, PhD, is an Associate Professor at the University of Bologna and Medical Executive in General Surgery and Transplantation in Sant’Orsola-Malpighi Hospital, Bologna. His clinical interest is HCC surgery, hepatic metastasis, bilious pancreatic tumors and liver transplantation, kidney transplantation, and multiorgan transplantation. He performed more of 2800 surgery operations, including hepatic resections (major, minor and laparoscopic), liver transplantation, kidney transplantation from living and cadaveric donator, nephrectomy. In 2006 he received an Award F. Mazzeo for the best scientific work in XXIII National congress S.I.P.A.D. He is author and co-author of more 251 scientific publications with 6708 citations of 5635 documents, with h-index 47.

Lun-Xiu Qin, MD, PhD, Professor & Director, Department of Surgery, Huashan Hospital; Institute of Cancer Metastasis, Fudan University. He is one of the founding members of the International Liver Cancer Association (ILCA), the member of Chinese Society of Surgery (Chinese Medical Association, CMA), the Chairman of Cancer Precision Treatment Society of Chinese Anti-Cancer Association (CACA), the Former Chairman of Cancer Metastasis Society of CACA and Shanghai Association of Tumor Molecular Target, member of CSCO. He is one of the Distinguished Young Scholars (China National Science Fund). He is also a Chang Jiang Scholar and the director of the Innovative Research Team (the Ministry of Education of China). He is focusing on the surgical treatment of hepatobiliary diseases as well as the translational study of metastatic recurrence of liver cancer. He is taking charge of many key projects including National Key Basic Research Program of China (973 Program) and the China National Key Projects for Infectious Disease, and has published over 120 papers in the peer-reviewed English journals including Cancer Cell, Cell Metabolism, Nat Med, Hepatology, Gut, Oncogene, Cancer Res, Clin Cancer Res, etc. He has got many scientific awards and honors from the government including the State Natural Science Award of China (2010).